Cargando…

Recombinant trail: a synergistic effect in myeloid leukemias

Detalles Bibliográficos
Autores principales:	Carvalho, Filipa, Coelho, A Sofia, Domingues, Cátia, Carvalho, João A, Ribeiro, André, Santos, Rui M, Gonçalves, A Cristina, Alves, Vera, Silva, Teresa, Dourado, Marília, Nascimento-Costa, José M, Sarmento-Ribeiro, Ana B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255044/

Ejemplares similares

Histone deacetylation - a new epigenetic target in cancer
por: Carvalho, João A, et al.
Publicado: (2010)

The role of CD26 and CD40 expression in therapeutic response - experimental study in oral cancer lines
por: Batista, Joana PN, et al.
Publicado: (2010)

PB1782: ZINC IN THE MODULATION OF THE ANTIPROLIFERATIVE AND CYTOTOXIC EFFECTS OF OLAPARIB IN ACUTE MYELOID LEUKEMIA
por: Costa, M. I., et al.
Publicado: (2022)

Combination of Elacridar with Imatinib Modulates Resistance Associated with Drug Efflux Transporters in Chronic Myeloid Leukemia
por: Alves, Raquel, et al.
Publicado: (2022)

Delocalized lipophilic cations as a new therapeutic approach in cancer
por: Ribeiro, A Barbosa, et al.
Publicado: (2010)

New targeted therapies in myelodysplastic syndrome: the role of farnesyltransferase and proteasome inhibitors
por: Gonçalves, A Cristina, et al.
Publicado: (2010)

P659: BUPARLISIB A PROMISING THERAPEUTIC APPROACH IN CHRONIC MYELOID LEUKEMIA RESISTANT TO IMATINIB
por: Alves, Raquel, et al.
Publicado: (2023)

Apoptosis and (in) Pain—Potential Clinical Implications
por: Ribeiro, Hugo, et al.
Publicado: (2022)

Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance
por: Alves, Raquel, et al.
Publicado: (2021)

Platelet Membrane Proteins as Pain Biomarkers in Patients with Severe Dementia
por: Ribeiro, Hugo, et al.
Publicado: (2023)

Monocytes in the Characterization of Pain in Palliative Patients with Severe Dementia—A Pilot Study
por: Ribeiro, Hugo, et al.
Publicado: (2023)

Zinc Prevents DNA Damage in Normal Cells but Shows Genotoxic and Cytotoxic Effects in Acute Myeloid Leukemia Cells
por: Costa, Maria Inês, et al.
Publicado: (2022)

Alvespimycin Inhibits Heat Shock Protein 90 and Overcomes Imatinib Resistance in Chronic Myeloid Leukemia Cell Lines
por: Alves, Raquel, et al.
Publicado: (2023)

Novel Non-Viral Vectors Based on Pluronic(®) F68PEI with Application in Oncology Field
por: Silva, Inês, et al.
Publicado: (2022)

Pediatric Drug Development: Reviewing Challenges and Opportunities by Tracking Innovative Therapies
por: Domingues, Cátia, et al.
Publicado: (2023)

PB1781: THERAPEUTIC POTENTIAL OF DNA DAMAGE RESPONSE IN ACUTE MYELOBLASTIC LEUKEMIA
por: Lapa, B., et al.
Publicado: (2022)

Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells
por: Lopes-Coelho, Filipa, et al.
Publicado: (2017)

Disseminated Saprochaete capitata fungal infection in a patient with acute myeloid leukemia
por: Duarte, Delfim, et al.
Publicado: (2021)

PB1856: DEMETHYLATING AGENTS AND HISTONE DEACETYLASE INHIBITORS AS NEW THERAPEUTIC STRATEGIES IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Jorge #, J., et al.
Publicado: (2022)

The Debate between the Human Microbiota and Immune System in Treating Aerodigestive and Digestive Tract Cancers: A Review
por: Domingues, Cátia, et al.
Publicado: (2023)

Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α
por: Alves, Raquel, et al.
Publicado: (2020)

Complex karyotype including ring chromosome 11 in a patient with acute myeloid leukemia: case report
por: Ornellas, Maria Helena Faria, et al.
Publicado: (2017)

The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
por: Ryu, Sunhyo, et al.
Publicado: (2018)

PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH
por: Carda #, J. P., et al.
Publicado: (2022)

Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia
por: Wang, Zixuan, et al.
Publicado: (2020)

Antitumor Effect of Brusatol in Acute Lymphoblastic Leukemia Models Is Triggered by Reactive Oxygen Species Accumulation
por: Jorge, Joana, et al.
Publicado: (2022)

The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells
por: Shi, Mingyue, et al.
Publicado: (2019)

Synergistic Lethality Effects of Apatinib and Homoharringtonine in Acute Myeloid Leukemia
por: Shi, Yuanfei, et al.
Publicado: (2022)

Metalloproteinase inhibitors as a potential therapeutic approach in multiple myeloma: a preliminary study
por: Pais, A Sofia, et al.
Publicado: (2010)

AZD-7648, a DNA-PK Inhibitor, Induces DNA Damage, Apoptosis, and Cell Cycle Arrest in Chronic and Acute Myeloid Leukemia Cells
por: Lapa, Beatriz Santos, et al.
Publicado: (2023)

PB1822: INHIBITION OF THE DNA DAMAGE RESPONSE: A POSSIBLE NEW ROUTE IN ACUTE MYELOBLASTIC LEUKEMIA TREATMENT
por: Lapa, Beatriz, et al.
Publicado: (2023)

The Synergistic Effects of Low Dose Fluorouracil and TRAIL on TRAIL-Resistant Human Gastric Adenocarcinoma AGS Cells
por: Zhu, Hong, et al.
Publicado: (2013)

Necrotizing fasciitis of the vulva due to carbapenem-resistant Enterobacteriaceae as a complication of acute myeloid leukemia treatment: a case report
por: Bento, Marta Leal, et al.
Publicado: (2022)

Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL
por: Bui, Hang Thi Thuy, et al.
Publicado: (2019)

AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia
por: Barbetti, V, et al.
Publicado: (2013)

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells
por: Tuthill, Mark H, et al.
Publicado: (2014)

Ants Can Learn to Forage on One-Way Trails
por: Ribeiro, Pedro Leite, et al.
Publicado: (2009)

MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1
por: Sun, Yan-ping, et al.
Publicado: (2016)

Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia
por: Ribeiro, Sara, et al.
Publicado: (2021)

Synergistic Action of Montmorillonite with an Intumescent Formulation: The Impact of the Nature and the Strength of Acidic Sites on the Flame-Retardant Properties of Polypropylene Composites
por: Martins, Raíssa Carvalho, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kl47plcvqkg9j8oc94sq7va8qj